Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
All news about MERCK & CO., INC.
02/01WALL STREET STOCK EXCHANGE : Return to growth
02/01MERCK : Gets Positive EU Opinion for Keytruda in Classical Hodgkin Lymphoma
DJ
02/01MERCK & CO., INC. : Change in Directors or Principal Officers, Financial Stateme..
AQ
02/01MERCK : Dr. Stephen Mayo Elected to Merck Board of Directors
BU
02/01Merck Appoints Stephen “Steve” L. Mayo to its Board of Directors Effective Ma..
CI
02/01MERCK : Receives Positive EU CHMP Opinion for Expanded Approval of KEYTRUDA® (pe..
BU
02/01Merck Receives Positive EU CHMP Opinion for Expanded Approval of KEYTRUDA® (p..
CI
02/01MERCK : Says Keytruda-Yervoy Combo Failed to Add Clinical Benefit to Non-Small C..
MT
02/01MERCK : Presents Results From Head-to-Head Phase 3 KEYNOTE-598 Trial Evaluating ..
AQ
01/29MERCK : Presents Results From Head-to-Head Phase 3 KEYNOTE-598 Trial Evaluating ..
BU
01/29Merck Presents Results From Head-to-Head Phase 3 KEYNOTE-598 Trial Evaluating..
CI
01/29S&P 500 Posts 3.3% Weekly Drop, Pulling January Into Red for 1.1% Monthly Dec..
MT
01/29MERCK : Partners with The END Fund to Supply Praziquantel Tablet to Rwanda
MT
01/28EISAI : To present investigational data on lenvima based combination therapies i..
AQ
01/27MERCK : to Construct New Facility in the United States to Expand Manufacturing C..
PU
01/27MERCK : Announces Second Cohort of Safer Childbirth Cities Organizations Committ..
BU
01/27MERCK : European Commission Approves KEYTRUDA as First-Line Treatment in Adult P..
AQ
01/27ENWAVE : Merck cites EnWave's REV Technology as a Faster, Viable Drying Alternat..
AQ
01/26MERCK : Declares Unchanged Quarterly Dividend of $0.65 Per Common Share, Payable..
MT
01/26MERCK : Announces Second-Quarter 2021 Dividend
BU
01/26Merck Announces Second-Quarter 2021 Dividend, Payable on April 7, 2021
CI
01/26MERCK : Says Interim Findings From Ongoing Mid-Stage Study Show Potential of Isl..
MT
01/26MERCK : Presents Interim Findings from Phase 2a Clinical Trial Evaluating Invest..
BU
01/26Merck Presents Interim Findings from Phase 2A Clinical Trial
CI
01/26MERCK : Secures European Commission's Approval of Keytruda as Monotherapy of Col..
MT
01/26MERCK : European Commission Approves Keytruda in Some Colorectal Cancers
DJ
01/26MERCK : European Commission Approves KEYTRUDA® (pembrolizumab) as First-Line Tre..
BU
01/26Merck Announces European Commission Approves KEYTRUDA® (pembrolizumab) as Fir..
CI
01/26MERCK : Discontinues Development of SARS-CoV-2/COVID-19 Vaccine Candidates, Cont..
AQ
01/25Merck Scraps Covid-19 Vaccine Candidates -- Update
DJ
01/25MERCK : Correction to Merck Scraps Covid-19 Vaccine Candidates Article
DJ
01/25MERCK : Thinking about trading options or stock in Niu Technologies, Regeneron P..
PR
01/25SECTOR UPDATE : Health Care Stocks Climb Premarket Monday
MT
01/25Merck ends development of two potential COVID-19 vaccines
AQ
01/25MERCK : Halts Development of COVID-19 Vaccine Candidates
MT
01/25MERCK : Stops Development of COVID-19 Vaccine Candidates V590 and V591
MT
01/25Merck Scraps Covid-19 Vaccine Candidates
DJ
01/25MERCK : Discontinues Development of SARS-CoV-2/COVID-19 Vaccine Candidates; Cont..
BU
01/25Merck Discontinues Development of SARS-CoV-2/COVID-19 Vaccine Candidates
CI
01/25MERCK : European Commission Authorizes Use Of Merck-Pfizer Cancer Drug Bavencio
MT
01/21MERCK : Announces U.S. FDA Approval of VERQUVO
AQ
01/21MERCK : Bayer - U.S. FDA approves vericiguat for patients with symptomatic chron..
AQ
01/20MERCK : Canada and MaRS Team Up to Launch Lung Cancer Innovation Challenge
AQ
01/20MERCK : Gets FDA Approval for Verquvo
DJ
01/20MERCK : Receives US FDA Approval of Heart Failure Treatment Verquvo
MT
01/20MERCK : Announces U.S. FDA Approval of VERQUVO® (vericiguat)
BU
01/20Merck Announces U.S. FDA Approval of VERQUVO
CI
01/20UPDATE : DeepMatter Jumps 18% on Multi-Year Data Licensing Contract with Merck's..
MT
01/20DeepMatter Lands Multi-Year Data Licensing Contract With Merck's Life Science..
MT
01/20Deepmatter Group plc's Wholly Owned Subsidiaries Enters into A Multi-Year, Li..
CI
01/14MERCK : Philips Partners with Merck to Develop Digital Systems for Fertility Tre..
MT
01/13LIGAND PHARMACEUTICALS INCORPORATED : to Receive $1.5 Million Milestone Payment ..
MT
01/13MERCK : Confirms Agreement with UNICEF to Establish the World's First Global Ebo..
PU
01/12EISAI : To present data on lenvima monotherapy and in combination with keytruda ..
AQ
01/12MERCK : Gets FDA Priority Review of V114 Vaccine for Adults
DJ
01/12MERCK : Says FDA Accepts for Priority Review the Biologics License Application f..
MT
01/12MERCK : U.S. FDA Accepts for Priority Review the Biologics License Application f..
BU
01/12U.S. FDA Accepts for Priority Review the Biologics License Application for V1..
CI
01/11MERCK : to Hold Fourth-Quarter and Full-Year 2020 Sales and Earnings Conference ..
AQ
01/08MERCK : Create Advisory Panel to Address Company-Wide Digital Ethics
MT
01/08MERCK : to Hold Fourth-Quarter and Full-Year 2020 Sales and Earnings Conference ..
BU
01/06CEOs Consider Ways to Smooth the Presidential Transition, Including Holding B..
DJ
01/05MERCK : Partners With Symvivo on BacTRL Platform Technology
MT
01/05Equities Climb in Early US Trading Led by Rise in Energy Sector as Oil Prices..
MT
01/04MERCK : to Present at the 39th Annual J.P. Morgan Healthcare Conference
BU
2020Merck & Co., Inc. completed the acquisition of OncoImmune, Inc. for approxima..
CI
2020MERCK : LYNPARZA Receives Three New Approvals in Japan
AQ
2020SECTOR UPDATE : Health Care Stocks Flat During Premarket Trading on Monday
MT
2020ASTRAZENECA : Japanese Regulator Approves AstraZeneca, Merck's Lynparza for Trea..
MT
2020MERCK : LYNPARZA® (olaparib) Receives Three New Approvals in Japan
BU
2020ASTRAZENECA AND MERCK ANNOUNCES LYNP : Ovarian, Prostate and Pancreatic Cancer
CI
2020GLOBAL MARKETS LIVE : Alibaba, Merck, Moderna…
2020MERCK : FDA's Oncologic Drugs Advisory Committee to Discuss Merck's Application ..
PU
2020MERCK : Working With A2 Biotherapeutics to Develop Investigational Cell Therapy ..
MT
2020MERCK : Lands $356 Million COVID-19 Treatment Supply Deal With US Government
MT
Prev.4  5  6  7  8   9  10  11  12  13Next
Upcoming event on MERCK & CO., INC.